An explainable multimodal machine-learning framework to predict progression from MCI to dementia within a clinically meaningful two-year period is developed and the convergence of cognitive impairment and region-specific neurodegeneration emerged as the strongest indicator of conversion risk.
Mild cognitive impairment (MCI) is a transitional state between normal aging and dementia, characterized by subtle cognitive decline. While not all individuals with MCI will progress to Alzheimer’s disease (AD), early identification of those at high risk is crucial for timely interventions. Machine learning algorit...
A. Mouiha, Mohamed Taiebine, Jaouad El-Hilaly· Journal of Education and Hea...· 0 citations
BACKGROUND: Subjective cognitive decline (SCD) may precede mild cognitive impairment (MCI), but not all individuals with SCD progress to MCI. Identifying which individuals are most likely to convert and over what time frame remains an important goal in Alzheimer's disease research. MRI measures of white matter hyperint...
F. Kamal, A. Metz, K. Chadwick et al.· medRxiv· 0 citations
Episodic memory demonstrated the strongest predictive performance among the individual assessment domains evaluated of 24-month progression from MCI to AD, with functional assessment providing substantial complementary value.
BackgroundWhile multiple biomarkers of Alzheimer's disease (AD) and mild cognitive impairment (MCI) predict cognitive decline over time, their predictive value at each of the disease stages remains unclear.ObjectiveTo examine how the predictive power of biomarkers changes over time.MethodsWe dynamically ranked a compre...
E. Ramezannezhad, Mohammad Dehghani· Journal of Alzheimer's Disea...· 0 citations
The findings support the potential role of structural MRI biomarkers combined with interpretable ML approaches for the classification of cognitive impairment and the integration of demographic variables improved model performance, particularly in binary discrimination tasks, whereas multiclass classification remained m...
Alzheimer’s disease (AD) is a progressive neurological disorder and the leading cause of dementia, affecting millions globally. As populations continue to age, AD prevalence is expected to rise significantly, placing substantial burdens on healthcare systems. Early detection of cognitive decline is essential, as interv...
Samaneh Rezaeimanesh, Mohammad Fili, Gui-Ping Hu et al.· IISE Annual Conference &...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.